Defined Diagnostics, LLC
5Patents
5Active
5Granted
44Portfolio score
Filing activity: Nov 30, 2012 → Jul 17, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9625465B2 | Clinical diagnostic systems | Emerging Cross-Sectional Technologies | 4 | Active |
| US9702869B2 | Assays, antibodies, immunogens and compositions related to 5-FU | Physics | 1 | Active |
| US11175295B2 | Antibodies and methods for the detection of cell death | Physics | 0 | Active |
| US11054430B2 | Compounds and methods for the detection of methotrexate | Chemistry; Metallurgy | 0 | Active |
| US11061028B2 | Compositions and methods for the diagnosis of lyme disease | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.